Evaxion Biotech A/S EVAX Stock
Evaxion Biotech A/S Price Chart
Evaxion Biotech A/S EVAX Financial and Trading Overview
Evaxion Biotech A/S stock price | 1.44 USD |
Previous Close | 1.3 USD |
Open | 1.33 USD |
Bid | 0 USD x 1200 |
Ask | 0 USD x 1000 |
Day's Range | 1.28 - 1.35 USD |
52 Week Range | 0.92 - 3.52 USD |
Volume | 89.59K USD |
Avg. Volume | 247.21K USD |
Market Cap | 34.11M USD |
Beta (5Y Monthly) | 0.568862 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -10 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.67 USD |
EVAX Valuation Measures
Enterprise Value | 28.45M USD |
Trailing P/E | N/A |
Forward P/E | -0.65816325 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 3.7499998 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -1.145 |
Trading Information
Evaxion Biotech A/S Stock Price History
Beta (5Y Monthly) | 0.568862 |
52-Week Change | -19.37% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3.52 USD |
52 Week Low | 0.92 USD |
50-Day Moving Average | 1.43 USD |
200-Day Moving Average | 1.82 USD |
EVAX Share Statistics
Avg. Volume (3 month) | 247.21K USD |
Avg. Daily Volume (10-Days) | 1.09M USD |
Shares Outstanding | 26.44M |
Float | 16.34M |
Short Ratio | 4.26 |
% Held by Insiders | 42.47% |
% Held by Institutions | 0.40% |
Shares Short | 254.31K |
Short % of Float | N/A |
Short % of Shares Outstanding | 0.95% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -24854000 USD |
Net Income Avi to Common (ttm) | -23619000 USD |
Diluted EPS (ttm) | -0.96 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 13.18M USD |
Total Cash Per Share (mrq) | 0.55 USD |
Total Debt (mrq) | 10.26M USD |
Total Debt/Equity (mrq) | 123.51 USD |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 0.344 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Evaxion Biotech A/S
Country | United States |
State | N/A |
City | Horsholm |
Address | Dr. Neergaards Vej |
ZIP | 2970 |
Phone | 45 53 53 18 50 |
Website | https://www.evaxion-biotech.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 63 |
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
Q&A For Evaxion Biotech A/S Stock
What is a current EVAX stock price?
Evaxion Biotech A/S EVAX stock price today per share is 1.44 USD.
How to purchase Evaxion Biotech A/S stock?
You can buy EVAX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evaxion Biotech A/S?
The stock symbol or ticker of Evaxion Biotech A/S is EVAX.
Which industry does the Evaxion Biotech A/S company belong to?
The Evaxion Biotech A/S industry is Biotechnology.
How many shares does Evaxion Biotech A/S have in circulation?
The max supply of Evaxion Biotech A/S shares is 6.32M.
What is Evaxion Biotech A/S Price to Earnings Ratio (PE Ratio)?
Evaxion Biotech A/S PE Ratio is now.
What was Evaxion Biotech A/S earnings per share over the trailing 12 months (TTM)?
Evaxion Biotech A/S EPS is -10 USD over the trailing 12 months.
Which sector does the Evaxion Biotech A/S company belong to?
The Evaxion Biotech A/S sector is Healthcare.
Evaxion Biotech A/S EVAX included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}